ARS Pharmaceuticals Inc SPRY Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
ARS Pharmaceuticals Inc (SPRY)
ARS Pharmaceuticals Inc (SPRY) Financials

ARS Pharmaceuticals Inc (SPRY)

14.53

0.16

(1.11%)

Closed 29 November 8:00AM

Delayed by 15 minutes

14.59

0.06

(0.41%)

After Hours: 11:59AM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-127.629	-110.974	-16.054	-24.573	-11.28	-21.128
Return on Equity (%)	100.517	51.127	-20.331	-25.687	-11.823	-21.589
Return on Invested Capital (%)	-210.007	-426.191	-17.492	-28.38	-13.694	-27.005
Operating Margin (%)	N/A	N/A	N/A	N/A	-2635.41	-181216.667
Net Profit Margin (%)	N/A	N/A	N/A	N/A	-2635.41	-181216.667
Book Value Per Share	27.697	-8.438	11.034	9.043	7.605	2.404
Earnings Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
Cash Per Share	30.685	15.024	11.14	7.321	5.867	0.739
Working Capital Per Share	23.796	-11.142	10.981	7.106	7.587	2.389
Operating Profit Per Share	N/A	N/A	N/A	N/A	0.037	N/A
EBIT Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
EBITDA Per Share	-26.756	-36.095	-0.949	-2.579	-0.967	-0.566
Free Cash Flow Per Share	-26.804	-36.77	-0.941	-2.562	-0.97	-0.565

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	657k	664k	34.7M	34.7M	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	35.88M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-74805	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	-74805	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	1.4B
Price to Earnings Ratio	-26.03
Price to Sales Ratio	48.53k
Price to Cash Ratio	19.94
Price to Book Ratio	6.13
Dividend Yield	-

Share Statistics

Shares Outstanding	97.19M
Average Volume (1 week)	969.23k
Average Volume (1 Month)	1.32M
52 Week Change	202.08%
52 Week High	18.49
52 Week Low	4.6525

More Ratios Coming Soon!

ARS Pharmaceuticals

Vanguard US Total Market...

Assembly Biosciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions